All Stories

  1. Mohs Micrographic Surgery for Head and Neck Nonmelanoma Skin Cancer: An Approach for Ent Surgeons
  2. Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection
  3. Clinical characteristics and incidence of glucose metabolism disorders during the follow-up of surgically treated insulinomas
  4. Embryonal Tumors of the Central Nervous System
  5. Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer
  6. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas
  7. Erratum to “Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism”
  8. Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation
  9. A 30-Year Long-Term Experience in Appendix Neuroendocrine Neoplasms—Granting a Positive Outcome
  10. Head and neck cutaneous basal cell carcinoma: what should the otorhinolaryngology head and neck surgeon care about?
  11. Juvenile gangrenous vasculitis of the scrotum – a diagnosis not to forget
  12. Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2
  13. Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism
  14. Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
  15. Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
  16. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma
  17. Periocular Sebaceous Carcinoma With Apocrine Differentiation: A Case Report and Review of the Literature
  18. Histological Subtypes and Clinical Behavior Evaluation of Salivary Gland Tumors
  19. Melanoma treatment in review
  20. Telomere Maintenance Mechanisms in Cancer
  21. Phenotypic Intratumoral Heterogeneity of Endometrial Carcinomas
  22. Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment
  23. Malignant Solitary Fibrous Tumor of the Liver:AIRP Best Cases in Radiologic-Pathologic Correlation
  24. Liver transplant recipients have a higher prevalence of anal squamous intraepithelial lesions
  25. Primary intimal sarcoma of the left atrium presenting with constitutional symptoms
  26. SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma
  27. Epigenetics in endometrial carcinogenesis – part 2: histone modifications, chromatin remodeling and noncoding RNAs
  28. Epigenetics in endometrial carcinogenesis – part 1: DNA methylation
  29. The role of pathology in the management of patients with endometrial carcinoma
  30. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis
  31. Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer
  32. Adipose Tissue Tumors, Stomach
  33. C-Kit (CD117), Gastrointestinal Stromal Tumors (GISTs)
  34. Distant Metastases in Uterine Leiomyosarcomas
  35. Gastrointestinal Autonomic Nerve Tumor
  36. Gastrointestinal Stromal Tumor
  37. Glomus Tumor, Gastrointestinal
  38. Granular Cell Tumor, Gastrointestinal
  39. Inflammatory Fibroid Polyp, Upper Gastrointestinal Tract
  40. Inflammatory Myofibroblastic Tumor, Upper Gastrointestinal Tract
  41. Neuroendocrine Tumor, Esophagus
  42. Neuroendocrine Tumor, Gastric
  43. Neuroendocrine neoplasms: a brief overview emphasizing gastroenteropancreatic tumors
  44. Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome
  45. TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes
  46. Spitz/Reed nevi: a review of clinical-dermatoscopic and histological correlation
  47. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism
  48. Metanephric adenoma: Cytological, histological, and molecular diagnosis of a case
  49. Mixed Adenoneuroendocrine Carcinoma Causing Colonic Intussusception
  50. Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium
  51. Basal cell carcinoma of the skin (part 1): epidemiology, pathology and genetic syndromes
  52. Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management
  53. “A book should not be judged by its cover”: two cases of intestinal adenocarcinoma as the first manifestation of Crohn’s disease
  54. Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors
  55. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy
  56. RE: TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
  57. Endometrial Carcinoma in Portugal
  58. A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide
  59. Pathophysiology of Infantile Pulmonary Arterial Hypertension Induced by Monocrotaline
  60. Pathology, therapy and prognosis of papillary renal carcinoma
  61. AIRP Best Cases in Radiologic-Pathologic Correlation: Gastroblastoma: A Rare Biphasic Gastric Tumor
  62. Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs)
  63. Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial
  64. TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation
  65. Telomerase promoter mutations in cancer: an emerging molecular biomarker?
  66. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas
  67. Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva
  68. PNET with neuroendocrine differentiation of the lung
  69. Tactoid body features in a Schwann cell hamartoma of colonic mucosa
  70. Frequency of TERT promoter mutations in human cancers
  71. GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells
  72. Feasibility of Fine-Needle Aspiration in the Diagnosis of Two Unusual Childhood Jaw Tumor Types: Prognoma and Cementifying Fibroma
  73. Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature
  74. Multiple Hepatic Inflammatory Pseudotumours Diagnosed after Laparoscopic Excisional Biopsy
  75. Simultaneous presentation of Kaposi sarcoma and HHV8-associated large B-cell lymphoma in the same lymph node: A rare diagnosis in an HIV-negative patient
  76. Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness
  77. Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma
  78. Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors
  79. Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: Case report and review of the literature
  80. mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma
  81. Insights into melanoma: targeting the mTOR pathway for therapeutics
  82. The mTOR Signalling Pathway in Human Cancer
  83. Melanocytic Tumour in a Black Sheep never exposed to Ultraviolet Radiation
  84. Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
  85. A Clear Cell Renal Cell Carcinoma Inhibiting the Response to Intravitreal Antivascular Endothelial Growth Factor Therapy in Wet Age-Related Macular Disease
  86. Paraganglioma of seminal vesicle and chromophobe renal cell carcinoma: a case report and literature review
  87. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms
  88. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes
  89. ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms
  90. ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
  91. ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas
  92. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors
  93. A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney–Stratakis dyad
  94. Abdominal inflammatory myofibroblastic tumor
  95. Endometrial Carcinomas
  96. Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome
  97. Black esophagus
  98. Human Endometrium Ultrastructure During the Implantation Window
  99. Identification of De Novo Germline Mutations in the HRPT2 Gene in Two Apparently Sporadic Cases with Challenging Parathyroid Tumor Diagnoses
  100. Dysplasia surveillance in an ulcerative colitis patient: Successful detection with Narrow band imaging and magnification
  101. mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics
  102. Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas
  103. Idiopathic Infantile Arterial Calcification: A Rare Cause of Sudden Unexpected Death in Childhood
  104. Endometrial endometrioid adenocarcinoma associated with primitive neuroectodermal tumour of the uterus: a poor prognostic subtype of uterine tumours
  105. Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre study
  106. Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma
  107. Angiogenesis and Breast Cancer
  108. ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors
  109. ENETS Consensus Guidelines for the Management of Peritoneal Carcinomatosis from Neuroendocrine Tumors
  110. ENETS Consensus Guidelines for the Management of Brain, Cardiac and Ovarian Metastases from Neuroendocrine Tumors
  111. Effects of Diabetes Mellitus, Pressure-Overload and Their Association on Myocardial Structure and Function
  112. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
  113. Loss of RKIP expression is associated with poor survival in GISTs
  114. Epidermolytic hyperkeratosis with palmoplantar keratoderma in a patient with KRT10 mutation
  115. Low frequency of MAP kinase pathway alterations inKITandPDGFRAwild-type GISTs
  116. Low-Grade Endometrial Stromal Sarcoma and Undifferentiated Endometrial Sarcoma: A Comparative Analysis Emphasizing the Importance of Distinguishing Between These Two Groups
  117. TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset
  118. Restrictive dermopathy—a lethal congenital laminopathy. Case report and review of the literature
  119. Cryptic chromosome rearrangement resulting in SYT-SSX2 fusion gene in a monophasic synovial sarcoma
  120. 583 POSTER Analysis of MAP kinase signalling pathway in KIT & PDGFRA wild-type GISTs
  121. Clinicopathological features of 45,X/46,Xidic(Y) mosaicism and therapeutic implications: case report
  122. Surgical Margin Status and Prognosis of Gastrointestinal Stromal Tumor
  123. Clear Cell Change in Colonic Polyps
  124. Epithelial-myoepithelial parotid carcinoma after kidney transplantation
  125. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas
  126. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma
  127. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Colon and Rectum Tumour/Carcinoma
  128. Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary
  129. Poorly-Differentiated Endocrine Carcinomas of Midgut and Hindgut Origin
  130. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Tumour/Carcinoma of the Appendix and Goblet Cell Carcinoma
  131. Splenic hamartomas in a dog
  132. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series
  133. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system
  134. A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation
  135. Association between Functional EGF+61 Polymorphism and Glioma Risk
  136. Multiple Myeloma Presenting with Malabsorption
  137. Gastrinoma (Duodenal and Pancreatic)
  138. Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic)
  139. Rare Functioning Pancreatic Endocrine Tumors
  140. Well-Differentiated Duodenal Tumor/Carcinoma (Excluding Gastrinomas)
  141. Well-Differentiated Gastric Tumors/Carcinomas
  142. Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma
  143. Orbital Metastasis as a Rare Form of Clinical Presentation of Non-small Cell Lung Cancer
  144. Deep-Seated Congenital Juvenile Xanthogranuloma
  145. Determining the least time required for measuring energy expenditure in premature neonates
  146. 183 POSTER Molecular alterations of KIT and PDGFR-alpha; in GISTs - A Portuguese experience
  147. Fluid supplementation for neonatal hyperbilerubinemia
  148. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
  149. Identification in Human Brain Tumors of DNA Sequences Specific for SV40 Large T Antigen
  150. Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
  151. Differential Prox-1 and CD 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumors
  152. Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneum
  153. Gingival Hyperplasia as a First Manifestation of Crohn's Disease
  154. Colonic Gastrointestinal Autonomic Nervous Tumor in a Patient with Crohn’s Disease
  155. Esophageal Gist: Therapeutic implications of an uncommon presentation of a rare tumor
  156. Epithelioid hemangioendothelioma and multiple thoraco-lumbar lateral meningoceles: two rare pathological entities in a patient with NF-1
  157. Mutation analysis of B-RAF gene in human gliomas
  158. Malignant peripheral nerve sheath tumour-like primary cutaneous malignant melanoma
  159. August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia
  160. Lipomatous haemangiopericytoma (adipocytic variant of solitary fibrous tumour) of the thyroid
  161. Cutaneous Malignant Melanoma: The Great Simulator
  162. Expression of c-met Tyrosine Kinase Receptor Is Biologically and Prognostically Relevant for Primary Cutaneous Malignant Melanomas
  163. Intraclonal diversity in a Sezary syndrome with a differential response to 2-deoxycoformycin of the two lymphoma cell populations
  164. Classic Kaposi's sarcoma of the tongue: Case report with emphasis on the differential diagnosis
  165. Idiopathic Perforation of the Gallbladder: A Novel Differential Diagnosis of Acute Abdomen
  166. Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin
  167. Carcinoma secretor da mama no adulto: existem parâmetros bem definidos para decisão terapêutica?
  168. Congenital composite hemangioendothelioma: case report and reappraisal of the hemangioendothelioma spectrum
  169. Response to Cyclosporine in a Patient With Disseminated Granuloma Annulare Associated With CD4+/CD8+(dim)/CD56+ Large Granular Lymphocytic Leukemia
  170. Chronic Eosinophilic Leukaemia Presenting with Erythroderma, Mild Eosinophilia and Hyper-IgE: Clinical, Immunological and Cytogenetic Features and Therapeutic Approach
  171. Hyaline Cell-rich Chondroid Syringoma: Case Report and Review of the Literature
  172. Primary acinic cell-like carcinoma of the breast-a variant with good prognosis?
  173. Genetic Profile of Gliosarcomas
  174. Adenocarcinoma of the cervix
  175. Microsatellite instability is not associated with degree of malignancy and p53 expression of gastrointestinal stromal tumours
  176. Time of remodelling of the patella tendon graft in anterior cruciate ligament surgery: an histological and immunohistochemical study in a rabbit model
  177. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins
  178. Synovial sarcoma: immunohistochemical expression of p-glycoprotein and glutathione s-transferase-pi and clinical drug resistance
  179. Proliferative Activity of Synovial Sarcoma: An Immunohistochemical Evaluation of Ki-67 Labeling Indices of 52 Primary and Recurrent Tumors
  180. Immunohistochemical Profile of Synovial Sarcoma with Emphasis on the Epithelial-type Differentiation
  181. Phacolytic glaucoma and lens-induced uveitis
  182. Critical Commentary
  183. Critical Commentary
  184. Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases
  185. The Ultrastructural Spectrum of Synovial Sarcomas: A Study of the Epithelial Type Differentiation of Primary Tumors, Recurrences, and Metastases
  186. Congenital Hereditary Corneal Dystrophy: Histologic and Ultrastructural Assessment of a Peculiar Polimorphic Recessive Form
  187. Dermatofibrosarcoma Protuberans
  188. Round cell sarcoma after clear cell sarcoma remission
  189. Thymic Tumors
  190. Cytogenetic study of a sclerosing stromal tumor of the ovary
  191. Common arterial trunk associated with absence of one atrioventricular connexion